FAM111A Gene Gracile bone dysplasia Genetic Test
Welcome to DNA Labs UAE, your trusted genetic testing lab in the UAE. In this blog post, we will be discussing the FAM111A Gene Gracile bone dysplasia Genetic Test, its cost, symptoms, diagnosis, and more.
Test Name: FAM111A Gene Gracile bone dysplasia Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Osteology Dermatology Immunology Disorders
Doctor: Dermatologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for FAM111A Gene Gracile bone dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FAM111A Gene Gracile bone dysplasia NGS Genetic DNA Test gene FAM111A
Test Details
The FAM111A gene is associated with a rare genetic disorder called gracile bone dysplasia. Gracile bone dysplasia is characterized by skeletal abnormalities, including thin and fragile bones, shortened limbs, and joint deformities. This condition is inherited in an autosomal recessive manner, meaning that both copies of the FAM111A gene must be mutated for the disorder to be present.
NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously. In the context of gracile bone dysplasia, NGS genetic testing can be used to identify mutations in the FAM111A gene. This test involves sequencing the entire coding region of the gene to identify any genetic variants or mutations that may be responsible for the disorder.
NGS genetic testing is a powerful tool that can provide a comprehensive analysis of multiple genes, allowing for a more accurate diagnosis and potentially identifying other genetic variants that may be contributing to the condition. It can also be used for carrier testing to determine if an individual carries a mutation in the FAM111A gene, even if they do not show any symptoms of gracile bone dysplasia.
Overall, NGS genetic testing for the FAM111A gene can aid in the diagnosis, management, and genetic counseling of individuals with gracile bone dysplasia and their families.
Test Name | FAM111A Gene Gracile bone dysplasia Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for FAM111A Gene Gracile bone dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FAM111A Gene Gracile bone dysplasia NGS Genetic DNA Test gene FAM111A |
Test Details |
FAM111A gene is associated with a rare genetic disorder called gracile bone dysplasia. Gracile bone dysplasia is characterized by skeletal abnormalities, including thin and fragile bones, shortened limbs, and joint deformities. This condition is inherited in an autosomal recessive manner, meaning that both copies of the FAM111A gene must be mutated for the disorder to be present. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously. In the context of gracile bone dysplasia, NGS genetic testing can be used to identify mutations in the FAM111A gene. This test involves sequencing the entire coding region of the gene to identify any genetic variants or mutations that may be responsible for the disorder. NGS genetic testing is a powerful tool that can provide a comprehensive analysis of multiple genes, allowing for a more accurate diagnosis and potentially identifying other genetic variants that may be contributing to the condition. It can also be used for carrier testing to determine if an individual carries a mutation in the FAM111A gene, even if they do not show any symptoms of gracile bone dysplasia. Overall, NGS genetic testing for the FAM111A gene can aid in the diagnosis, management, and genetic counseling of individuals with gracile bone dysplasia and their families. |